CVS Health stock holds near USD 90 after UBS cut

Published on 09/19/2026 at 12:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS cut CVS Health to USD 118 from USD 126 on September 9, 2026. CVS Health stock closed at USD 90.25 on September 17, 2026, after Q2 revenue of USD 106.10 billion.

Moderner Apothekenverkaufsraum mit Apothekerin und Kundin vor Medikamentenregalen — CVS Health Corp. zeigt fotorealen Apothekenverkaufsraum mit Apothekerin und Kundin, ISIN US1266501006, Illustration mit AI erstellt.

CVS Health stock (ISIN US1266501006) closed at USD 90.25 on September 17, 2026, down 1.60 percent on the day, with market capitalization near USD 115.43 billion. UBS cut its price target to USD 118 from USD 126 on September 9, 2026, while keeping a Buy rating, and that kept valuation at the center of the latest debate.

Q2 revenue beat

CVS reported second-quarter 2026 revenue of USD 106.10 billion and adjusted EPS of USD 2.58, according to MarketBeat's earnings overview dated September 18, 2026. The same source said revenue was 7.3 percent above the prior year and EPS beat the USD 1.87 consensus by USD 0.71.

CVS Health also raised full-year 2026 adjusted EPS guidance to USD 7.90 to USD 8.10, and MarketBeat's overview put the consensus at about USD 8.02. That leaves the stock trading below the average target of USD 107.24 that MarketBeat compiled on September 18, 2026.

Margin and valuation

Bernstein raised its target to USD 112 from USD 106 on September 10, 2026, while keeping an Outperform rating, according to Investing.com. The same report said Bernstein pointed to a faster-than-expected Aetna turnaround and more cautious assumptions for health services because of 340B pricing pressure.

For investors, the comparison is clear: CVS traded at USD 90.25 on September 17, 2026, against a 52-week range of USD 69.51 to USD 110.68, so the shares sat closer to the upper half of that band than to the low. MarketBeat also showed 22 Buy ratings and 1 Hold rating in its analyst overview.

Price and range

As of September 17, 2026, CVS Health stock was quoted at USD 90.25 on the New York Stock Exchange, with volume near 7.43 million shares and prior close at USD 91.72. The stock remains below the USD 110.68 52-week high, while the USD 69.51 low still frames the downside band.